Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US1638511089
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG005H82GB2
CC
Chemours Co
GICS: Materials · SECTOR: EQTY · SUB-SECTOR: Chemicals - Specialty
NAME
Chemours Co
ISIN
US1638511089
TICKER
CC
MIC
XNYS
REUTERS
CC.N
BLOOMBERG
CC US
Di., 10.12.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide (TiO2) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 29.11.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC) today announced the successful repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan under its senior secured term loan facility due in August 2028. The repricing reduces the applicable margin in respect of the Company’s $1,070,000,000 senior secured U.S. dollar-denominated term loan facility,...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 27.11.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $600,000,000 in aggregate principal amount of 8.000% senior unsecured notes due 2033 (the “Notes”) that was exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes are Ch...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Do., 14.11.2024       Chemours
US1638511089

Das Instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 15.11.2024 The instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY has its ex-dividend/interest day on 15.11.2024...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 13.11.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $600,000,000 aggregate principal amount of new 8.000% senior notes due 2033 (the “Notes”). The Notes will bear interest at 8.000% per annum and mature on January 15, 2033. Interest on the Notes will be payable semi-annually on Jan...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 13.11.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2033 (the “Notes”), subject to market and other conditions. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. Chemours intends to use the...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 04.11.2024       Chemours
US1638511089

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the third quarter 2024 and provided an update on the C...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 25.10.2024       Chemours
US1638511089

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Chemours Company (NYSE: CC). On February 29, 2024, the Company disclosed that the filing of its annual report for 2023 was delayed, that it “is evaluating one...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 23.10.2024       Chemours
US1638511089

The Chemours Company (“Chemours”) (NYSE: CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024. About The Che...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 14.10.2024       Chemours
US1638511089

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its third quarter 2024 financial results before market on Monday, November 4, 2024. The Company expects to hold its conference call to discuss its third quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Monday, Novemb...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Sa., 12.10.2024       Chemours
US1638511089

NEW ORLEANS, Oct. 11, 2024 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into The Chemours Company (NYSE: CC)....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 30.09.2024       Chemours
US1638511089

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Chemours Company (NYSE: CC). On February 29, 2024, the Company disclosed that the filing of its annual report for 2023 was delayed, that it “is evaluating one...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 09.09.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC), a global leader in delivering innovative performance chemistry, today announced the development of a low global warming potential (GWP) refrigerant retrofit approach for the automotive aftermarket to support the global phasedown of higher GWP hydrofluorocarbon (HFC) refrigerants. The technical approach d...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 04.09.2024       Chemours
US1638511089

NEW YORK, Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Di., 27.08.2024       Chemours
US1638511089

NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 19.08.2024       Chemours
US1638511089

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CC....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 18.08.2024       Chemours
US1638511089

NEW YORK, Aug. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 14.08.2024       Chemours
US1638511089

Das Instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 15.08.2024 The instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY has its ex-dividend/interest day on 15.08.2024...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Di., 13.08.2024       Chemours
US1638511089

The Chemours Company (Chemours) (NYSE: CC), a global leader in delivering innovative performance chemistry, today announced the opening of the Chemours Battery Innovation Center (CBIC), a first-in-its-class laboratory facility located at the Chemours Discovery Hub in Newark, Delaware. A multi-million-dollar investment, the CBIC supports the testin...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 11.08.2024       Chemours
US1638511089

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CC....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Fr., 09.08.2024       Chemours
US1638511089

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  The Chemours Company ("Chemours" or the "Company") (NYSE: CC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 20.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 20, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims again...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 20.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 20, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgat...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 20.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 20, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 20.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 20, 2024) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) and certain of its officers.Class Definition:This lawsuit seeks to recover damages against...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 19.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 19, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Fe...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 19.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 19, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 19.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 19, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims again...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 19.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 19, 2024) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) and certain of its officers.Class Definition:This lawsuit seeks to recover damages against...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Sa., 18.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 18, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Fe...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Sa., 18.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 18, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 17.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 17, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Fe...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 17.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 17, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchase...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 17.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 17, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated th...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Do., 16.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 16, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims again...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Do., 16.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 16, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Do., 16.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 16, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgat...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 15.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 15, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchase...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mi., 15.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 15, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of The Chemours Company ("Chemours") (NYSE: CC) breached their fiduciary duties to Chemours and its shareholders. If you are...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Di., 14.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 14, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchase...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 13.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 13, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims again...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 13.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 13, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchase...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 13.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 13, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgat...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Mo., 13.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 13, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Fe...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
So., 12.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 12, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims again...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Sa., 11.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 11, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Fe...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Sa., 11.05.2024       Chemours
US1638511089

Das Instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 13.05.2024 und ex Dividende/Zinsen am 14.05.2024 The instrument 2CU US1638511089 CHEMOURS CO. DL-,01 EQUITY has its pre-dividend/interest day on 13.05.2024 and its ex-dividend/interest day on 14.05.2024...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 10.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 10, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchase...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Fr., 10.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 10, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink
Do., 09.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 9, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that...
Zur Nachricht
Chemours
Charts & Research Termsheets Terminal
Permalink